在加利福尼亚州的第一个三年经验的粘多糖症I型新生儿查
Toki Fillman1, Jamie Matteson1, Hao Tang1
1Genetic Disease Screening Program, California Department of Public Health, Richmond, CA.
The Journal of pediatrics
|July 29, 2023
概括
加利福尼亚州加利福尼亚州加利福尼亚州
科学领域:
- 新生儿查 新生儿查
- 代谢障碍 代谢障碍 代谢障碍
- 遗传性疾病是一种遗传性疾病.
背景情况:
- 粘多糖症I型 (MPS I) 是一种罕见的遗传性疾病.
- 新生儿查 (NBS) 的目标是早期检测和干预.
- 加利福尼亚州在2018年为MPS I实施了通用NBS.
研究的目的:
- 为了评估加利福尼亚州MPS I NBS的最初3年.
- 为了确定一个大,多样化的人口中MPS I的出生患病率.
- 评估双层查方法的有效性.
主要方法:
- 采用了双层选策略:IDUA酶活性测定,然后进行DNA测序.
- 在2018年8月至2021年8月期间,超过120万名新生儿进行了查.
- 阳性查被转介给专业的随访和诊断.
主要成果:
- 确定MPS I的出生患病率为143,946.6分之一.
- 确定了7例严重的MPS I (Hurler综合征) 和2例减弱的MPS I病例.
- DNA测序揭示了一系列IDUA变异,包括致病性和不确定的意义.
结论:
- 双层NBS方法成功地发现了MPS I的新生儿,使得早期治疗成为可能.
- 对赫勒综合征的早期诊断和干预至关重要.
- 持续的跟踪对于了解MPS I基因型-表型相关性至关重要.
关键词:
伊杜瓦伊杜瓦 伊杜瓦伊杜瓦国家储备银行 (NBS) 是国家储备银行.溶酶体储存障碍 溶酶体储存障碍第一种类型的粘多糖症.新生儿的干血斑点在新生儿身上出现.α-L-iduronidase 的使用情况.更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...


